ISAKOS2017: Assessment of topical TXA efficacy in reverse total shoulder arthroplasty .
Reduced blood loss with low-volume topical tranexamic acid after RSA
43 patients scheduled for reverse shoulder arthroplasty were randomized to either topical tranexamic acid during closure or a control group which did not receive tranexamic acid. Patients were assessed for postoperative blood loss to drainage, transfusion rate, and complications. Postoperative drainage volume was significantly lower in the topical TXA group compared to the control group. No patient of either group required transfusion.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
